Diabetes
| Sleep apnea
Diabetes
Sleep apnea
Role of tirzepatide in obesity-related OSA
book_2
Source:
ADA 2024 - Symposium
calendar_today
Published on Medfyle:
July 2024
import_contacts
5
min
In this medfyle
Sleep-disordered breathing in people with OSA is associated with major cardiovascular complications, and excess weight is a significant risk factor. But new data from the SURMOUNT-OSA trials suggests incretin-based therapy with tirzepatide could be the answer.
About this Medfyle
Read more
arrow_downward
Hide
arrow_upward
©2024 Medfyle. All rights reserved.
Source: SURMOUNT-OSA Trial Results and Potential Role of Tirzepatide in Treating Obesity-Related Obstructive Sleep Apnea Symposium. ADA 2024; CT-SY49-1.5.
The information and data provided is for information purposes only. The author(s) of the original original presentation had no involvement in the creation of this content.
